His story underscores the expanding role of lumbar TDR as a preferred option for appropriately selected patients with multi-level degenerative disc disease. About Dr. Jason M. Cuéllar ...

The company is also developing MSC therapies for other indications, including adult GvHD, inflammatory bowel diseases, heart failure, and chronic lower back pain due to degenerative disc disease.